Markhard, Andrew L.
Broad Institute · Howard Hughes Medical Institute · Harvard University · Massachusetts General Hospital
3 papers on CoChat
Most cited papers
- Verified
Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids
Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S., & Sabatini, D. M. (2010) · Cell
PI3K/AKT/mTOR signaling in cancerAutophagy in Disease and Therapy
Cited by 2,464
- Verified
Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1 H)-one as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of Cancer
Liu, Q., Chang, J. W., Wang, J., Kang, S. A., Thoreen, C. C., Markhard, A., Hur, W., Zhang, J., Sim, T., Sabatini, D. M., et al. (2010) · Journal of Medicinal Chemistry
PI3K/AKT/mTOR signaling in cancerHeterocyclic Compound Synthesis and Bioactivity
Cited by 257
- Verified
Genetic Screen for Cell Fitness in High or Low Oxygen Highlights Mitochondrial and Lipid Metabolism
Jain, I. H., Calvo, S. E., Markhard, A. L., Skinner, O. S., To, T.-L., Ast, T., & Mootha, V. K. (2020) · Cell
Cancer, Hypoxia, and MetabolismRedox biology and oxidative stress
Cited by 224
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free